Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease Manifestations

• Nadera J. Sweiss ,

  * E-mail: nsweiss@medicine.bsd.uchicago.edu

  Affiliation Sarcoidosis and Scleroderma Clinic, Section of Rheumatology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Rafah Salloum,

  Affiliation Section of Rheumatology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Seema Ghandi,

  Affiliation Department of Medicine, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Maria-Luisa Alegre,

  Affiliation Section of Rheumatology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Ray Sawaqed,

  Affiliation Methodist Hospital, Merrillville, Indiana, United States of America

  ⨯
• Maria Badaracco,

  Affiliation Section of Rheumatology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Kenneth Pursell,

  Affiliation Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• David Pitrak,

  Affiliation Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Robert P. Baughman,

  Affiliation Division of Pulmonary and Critical Care, University of Cincinnati Medical Center, Cincinnati, Ohio, United States of America

  ⨯
• David R. Moller,

  Affiliation Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Joe G. N. Garcia,

  Affiliation Section of Pulmonary/Critical Care, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Timothy B. Niewold

  Affiliation Section of Rheumatology, University of Chicago, Chicago, Illinois, United States of America

  ⨯